Exelixis (EXEL) Notes Payables (2010 - 2016)
Exelixis (EXEL) recorded quarterly Notes Payables of $80.0 million in Q4 2016, little changed quarter-over-quarter from $80.0 million in Q3 2016.
Exelixis (EXEL) Notes Payables (2010 - 2016) Analysis & Trends
Exelixis' Notes Payables history runs 7 years deep, the most recent figure standing at $80.0 million for Q4 2016.
- In Q4 2016, Notes Payables changed N/A year-over-year to $80.0 million; the TTM figure through Dec 2016 stood at $80.0 million (changed N/A YoY), while the FY2016 annual figure was $80.0 million, changed N/A from the prior year.
- Notes Payables was $80.0 million for Q4 2016 at Exelixis, roughly flat from $80.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $80.0 million in Q2 2016 to a low of $164000.0 in Q1 2015.
- Historically, Notes Payables has averaged $16.7 million across 5 years, with a median of $2.7 million in 2013.
- The sharpest annual moves came in 2013 and 2015: Notes Payables slipped 19.38% in 2013, then tumbled 88.22% in 2015.
- A 5-year view of Notes Payables shows it stood at $3.2 million in 2012, then sank by 44.42% to $1.8 million in 2013, then plunged by 78.38% to $381000.0 in 2014, then slumped by 56.96% to $164000.0 in 2015, then jumped by 48680.49% to $80.0 million in 2016.
- The last three Notes Payables figures came in at $80.0 million (Q4 2016), $80.0 million (Q3 2016), and $80.0 million (Q2 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2016 | 80.00 Mn |
| Sep 30, 2016 | 80.00 Mn |
| Jun 30, 2016 | 80.00 Mn |
| Mar 31, 2015 | 164,000.00 |
| Dec 31, 2014 | 381,000.00 |
| Sep 30, 2014 | 757,000.00 |
| Jun 30, 2014 | 1.08 Mn |
| Mar 31, 2014 | 1.39 Mn |
| Dec 31, 2013 | 1.76 Mn |
| Sep 30, 2013 | 2.13 Mn |
| Jun 30, 2013 | 2.55 Mn |
| Mar 31, 2013 | 2.86 Mn |
| Dec 31, 2012 | 3.17 Mn |
| Sep 30, 2012 | 3.16 Mn |
| Jun 30, 2012 | 3.16 Mn |
| Mar 31, 2012 | 4.02 Mn |
| Dec 31, 2011 | 4.87 Mn |
| Sep 30, 2011 | 5.97 Mn |
| Jun 30, 2011 | 7.63 Mn |
| Dec 31, 2010 | 8.85 Mn |